Although both Sulfz and Galan produced similar reduction in NF-κB activity, however, the overall protective effect of Galan on colitis was more obvious than that of Sulfz implicating that other anti-inflammatory mechanisms or signaling pathways might play a role. This evidence concerns the gene NFKB1 and colitis.